PADI2 and rheumatoid arthritis: The findings that anti-PAD2 antibodies are associated with less inflammatory and progressive joint disease and a lower frequency of CT-ILD, coupled to their lack of association with traditional RA-associated HLA alleles and serologies, set them apart from other RA autoantibodies described to date.